Methods: We performed a retrospective chart review of outpatients treated with FMT by colonoscopy for recurrent CDI at the University of Virginia Health System from 6/2012 to 3/2015 and collected data on patient demographics, laboratory results, and patient outcomes. Per our clinic protocol, patients were closely followed with phone calls at 1 week and 3 and 6 months. Each patient is seen in clinic 1 month following FMT. For this review, we evaluated patients’ responses to questions about their overall health and quality of life, as well as specific symptoms of changes in bowel habits, abdominal pain, energy, and appetite. CDI recurrence was also examined.
Results: Fifty patients had FMT with an average age of 67 years ± 17 SD; 80% of the cohort was female. We have 1 month follow-up on 30 patients, 3 month follow-up on 35 patients, and 6 month follow-up on 27 patients. CDI recurrence occurred in 4 patients with 1 patient recurring at 1 and 3 months. A majority reported an improvement in their overall health (n=23, 77%) at 1 month, 3 months (n=30, 86%), and 6 months (n=26, 96%). Most patients also reported improvement in their abdominal pain (n=21, 70%) at 1 month, 3 months (n=25, 71%), and 6 months (n=22, 81%). Seventy percent of patients experienced ≤3 bowel movements a day at 1 month compared to 78% at 6 months. An increase in energy level was noted by patients at 1 month (n=15, 50%) and 6 months (n=20, 74%). Thirty-seven percent reported an improved appetite at 1 month compared to 56% at 6 months.
Conclusion: At our institution, most patients with recurrent CDI reported an improvement in quality of life after FMT, as well as normalization of their bowel habits, a decrease in abdominal pain, and an increase in energy and appetite. Our success rate for treatment of recurrent CDI is 92%, comparable to published reports. Though the cohort is small, our data suggests that patients treated with FMT experience health benefits beyond treatment of their infection.
G. L. Kolling, None
S. Vance, None
C. Warren, None
R. Guerrant, None
L. Archbald-Pannone, None